SmithaSKrishnamurthiMD

Clinical Trials

• Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Start of enrollment: 2000 Jun 01

  Completed

  Phase 2

• Erlotinib, Modified FOLFOX6, and Bevacizumab as First-Line Therapy Metastatic Colorectal Cancer Start of enrollment: 2005 Mar 01

  Completed

  Phase 1

• Dose Dense Therapy and Bevacizumab in Solid Tumors and Colorectal Cancer Start of enrollment: 2006 Mar 01

  Terminated

  Phase 1

• Sunitinib and Gemcitabine in Treating Patients With Pancreatic Cancer or Other Solid Tumors Start of enrollment: 2007 Mar 01

  Completed

  Phase 1

• Study of Modified Docetaxel, Cisplatin, and Fluorouracil (mDCF) in Unresectable or Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma Start of enrollment: 2006 Oct 23

  Completed

  Phase 2

• A Phase 1 Study of Safety and Bioactivity With FG-3019 in Combination With Gemcitabine and Erlotinib for Subjects With Locally Advanced or Metastatic Pancreatic Cancer Start of enrollment: 2008 Dec 01

  Completed

  Phase 1

• Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers Start of enrollment: 2010 Oct 01

  Terminated

  Phase 2

• Cholecalciferol(25-[OH]-Vitamin D) in Treating Patients With Colorectal Cancer Start of enrollment: 2012 Apr 01

  Withdrawn

  Early Phase 1

• An Extension Study of NKTR-102 in Cancer Patients Previously Enrolled in NKTR-102 Studies Start of enrollment: 2011 Oct 01

  Completed

  Phase 2

• Metformin Plus Modified FOLFOX 6 in Metastatic Pancreatic Cancer Start of enrollment: 2013 Feb 21

  Completed

  Phase 2

• A Study in Cancer Patients to Evaluate the Effect of a Single Dose of NKTR-102 (Etirinotecan Pegol) on the QTc Interval and to Assess Pharmacokinetics and Safety Start of enrollment: 2014 Feb 01

  Completed

  Phase 1

• Join now to see all